Kabi, Mylan and Neptune Thwarted In US Pemetrexed Proceedings

 
• By Aidan Fry
  
StopSign
A US Court of Appeals ruling has halted potential generics of Lilly's Alimta pemetrexed brand until 2022 • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin